AbbVie Inc. (NEO:ABBV)
26.95
-0.22 (-0.81%)
May 13, 2025, 4:00 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Immunology |
Log In |
Log In |
Log In |
Log In |
Immunology Growth |
Log In |
Log In |
Log In |
Log In |
Oncology |
Log In |
Log In |
Log In |
Log In |
Oncology Growth |
Log In |
Log In |
Log In |
Log In |
Other Key Products |
Log In |
Log In |
Log In |
Log In |
Other Key Products Growth |
Log In |
Log In |
Log In |
Log In |
All Other |
Log In |
Log In |
Log In |
Log In |
All Other Growth |
Log In |
Log In |
Log In |
Log In |
Neuroscience |
Log In |
Log In |
Log In |
Log In |
Neuroscience Growth |
Log In |
Log In |
Log In |
Log In |
Women's Health |
Log In |
Log In |
Log In |
Log In |
Women's Health Growth |
Log In |
Log In |
Log In |
Log In |
Aesthetics |
Log In |
Log In |
Log In |
Log In |
Aesthetics Growth |
Log In |
Log In |
Log In |
Log In |
Eye Care |
Log In |
Log In |
Log In |
Log In |
Eye Care Growth |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States |
Log In |
Log In |
Log In |
Log In |
United States Growth |
Log In |
Log In |
Log In |
Log In |
International |
Log In |
Log In |
Log In |
Log In |
International Growth |
Log In |
Log In |
Log In |
Log In |